A well-known syn­thet­ic prostaglandin ana­log, Bimato­prost is an effec­tive drug for treat­ing glau­co­ma. It is also effec­tive for treat ocu­lar hyper­ten­sion. It reduces the intraoc­u­lar pres­sure by increas­ing the out­flow of aque­ous liq­uid from the eyes. In 2008, the Food and Drug Admin­is­tra­tion approved bimato­prost to be used for cos­met­ic pur­pos­es, length­en­ing eye­lash­es.

Uses of Bimatoprost

Open angle glau­co­ma, one of the most com­mon forms of glau­co­ma is effec­tive­ly treat­ed by bimato­prost. It reduces ele­vat­ed intraoc­u­lar pres­sure in patients suf­fer­ing from open angle glau­co­ma or ocu­lar hyper­ten­sion. Patients who are intol­er­ant of oth­er intraoc­u­lar pres­sure drugs or who have not ade­quate­ly to anoth­er intraoc­u­lar pres­sure low­er­ing drug can cer­tain­ly ben­e­fit from bimato­prost eye drops. Usu­al­ly one drop of a 0.03% solu­tion is advised for peo­ple suf­fer­ing from glau­co­ma ; how­ev­er, you should always con­sult your doc­tor before using. It is also advised that you use the med­ica­tion same time every day.

Cau­tions of Bimatoprost

Some of the patients using this med­ica­tion have report­ed mac­u­lar ede­ma, includ­ing cys­toid mac­u­lar ede­ma. This eye drop should be used with cau­tion in apha­kic patients, patients with known risk fac­tors for mac­u­lar ede­ma and pseudopha­kic patients with a torn pos­te­ri­or lens cap­sule. In addi­tion to this, the drug has cer­tain side effects ; how­ev­er, these are expe­ri­enced rarely. The com­mon adverse effects include pig­men­ta­tion of peri­oc­u­lar skin, con­junc­ti­val hyper­emia, eye­lid ery­the­ma, ble­phar­i­tis and super­fi­cial punc­tu­ate ker­ati­tis. Ocu­lar effects of this drug involve increase in brown pig­men­ta­tion of the iris, peri­or­bital tis­sue and pig­men­ta­tion of eye­lash­es. Increased pig­men­ta­tion of iris devel­ops slow­ly, but may not be evi­dent until after sev­er­al months to years of bimato­prost ther­a­py.

Bimato­prost Pharmacokinetics

After top­i­cal appli­ca­tion, reduc­tion in intraoc­u­lar pres­sure gen­er­al­ly occurs after 4 hours. When applied, the drug is mod­er­ate­ly dis­trib­uted into body tis­sues with a steady state vol­ume of dis­tri­b­u­tion of 0.67 L/​kg and main­ly resides in the plas­ma. It is essen­tial that you learn and adhere to prop­er admin­is­tra­tion tech­niques in order to avoid con­t­a­m­i­na­tion of the solu­tion with com­mon bac­te­ria. If this is not done, ocu­lar infec­tions may occur. In severe sit­u­a­tion, where con­t­a­m­i­nat­ed oph­thalmic solu­tions are used, seri­ous dam­age to the eye and sub­se­quent loss of vision may be the result. Also, make sure that you inform your doc­tor if you are on med­ica­tion. Wat­son Inter­na­tion­al man­u­fac­tures high qual­i­ty bimato­prost at extreme­ly afford­able rates. Con­tact us if you need cus­tom made bimato­prost for your busi­ness. In addi­tion to this prostaglandin ana­log, we also offer chem­i­cals such as synthet­ic amino sug­ar com­pounds, man­del­ic acid sig­ma, etc.